<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>474-SORBITOL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="SORBITOL" rxcui="9945">
<ATC code="A06AD18" />
<ATC code="A06AG07" />
<ATC code="B05CX02" />
<ATC code="V04CC01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="The French document lists “Catioresine Sulfo Calcique”" >
</DRUG>
</DRUG2>
<DESCRIPTION>With the resin administered by oral and rectal route: risk of colonic necrosis, possibly fatal</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>474-SORBITOL.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="SORBITOL" rxcui="9945">
<ATC code="A06AD18" />
<ATC code="A06AG07" />
<ATC code="B05CX02" />
<ATC code="V04CC01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="The French document lists “Catioresine Sulfo Sodique”" >
</DRUG>
</DRUG2>
<DESCRIPTION>With the resin administered by oral and rectal route: risk of colonic necrosis, possibly fatal. </DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
